Our website uses cookies so that we can provide you a better online experience and service;
by continuing, you agree to our use of cookies in line with our Privacy Statement
Close
Open submenu
29 May 2017 - 10:00

Bifidobacterium lactis HN019™ Recorded for Foods with Function Claims in Japan

Food products containing Bifidobacterium lactis HN019™ from the DuPont™ Danisco® range have recently been recorded with the Consumer Affairs Agency, Government of Japan, for Food with Function Claims, further reinforcing the strength of science behind DuPont’s probiotics. HN019™ is the first Bifidobacterium lactis strain which allows a food manufacturer to state a health claim on the product.

Currently, drinkable yogurts, yogurts, and dietary supplements containing HN019™ as a functional ingredient have been recognized for claims stating to improve microflora and defecation for those suffering from constipation by adjusting intestinal environments. This further validates the strong scientific evidence DuPont has on the link between digestive health and probiotics.

Strong Science Behind Digestive Health

The Foods with Function Claims was first introduced in April 2015 to allow products to be clearly labeled with certain nutritional or health functions and to enable consumers to make more informed choices. Food business operators can make function claims on food labels when they submit to the Secretary-General of the Consumer Affairs Agency necessary information including scientific evidence on food safety and effectiveness in accordance with the rules prescribed by the law before marketing the product. 

“This is an important milestone for us. This recording of function claim on food labels will provide new opportunities for food, beverage and dietary supplement manufacturers to further promote this benefit to end consumers.” comments Hiroko Tanaka, regulatory affairs manager, DuPont Nutrition & Health, Japan.

New opportunities with Foods with Function Claims

Food manufacturers who use HN019™ in their finished products will now have a more cost effective and efficient way to utilize existing, robust data based on this strain. They will be permitted to print “This product contains Bifidobacterium lactis (HN019™). Bifidobacterium lactis (HN019™) is reported to improve defecation for those suffering from constipation by adjusting intestinal environment.” on their packaging labels. 

“We are extremely pleased with this newly recorded claim on food products containing HN019™.” says Yuta Nakazawa, DS Sales Manager of DuPont Nutrition & Health, Japan. “This is a win-win situation for both our customers and their consumers, especially for small to medium sized companies who do not have their own strains. They can now file for application with the Secretary-General of the Consumer Affairs Agency to include HN019™ in their food products which allows them to make function claims on their food labels. This will definitely provide a competitive edge to companies to be better differentiated in the marketplace.” he adds. 

 

DuPont Nutrition & Health combines in-depth knowledge of food and nutrition with current research and expert science to deliver unmatched value to the food, beverage and dietary supplement industries. We are innovative solvers, drawing on deep consumer insights and a broad product portfolio to help our customers turn challenges into high-value business opportunities. www.food.dupont.com  

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit www.dupont.com.

Makiko Oiwa
Direct:
+81 03-5521-2780